Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
National Cancer Institute, Egypt
M.D. Anderson Cancer Center
University of Chicago
Maia Biotechnology
Washington University School of Medicine
Medical University of South Carolina
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Seoul National University Bundang Hospital
UNC Lineberger Comprehensive Cancer Center
University of Maryland, Baltimore
Merck Sharp & Dohme LLC
Massachusetts General Hospital
UNC Lineberger Comprehensive Cancer Center
University of Chicago
University of Pittsburgh
Mayo Clinic
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
UNICANCER
University of Kentucky
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
QBiotics Group Limited
UNICANCER
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Dana-Farber Cancer Institute
University of Pittsburgh
Dana-Farber Cancer Institute
Thomas Jefferson University
University of Pittsburgh
University of Birmingham
Memorial Sloan Kettering Cancer Center
University of Chicago
Massachusetts General Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
Children's Hospital Medical Center, Cincinnati
University of Alabama at Birmingham
Stanford University
Case Comprehensive Cancer Center
Gruppo Oncologico del Nord-Ovest